Lillian Siu, MD

university-health-network-toronto

Part C2: Abiraterone acetate combination with AZD8186

Part D1: AZD2014 combination with AZD8186

Part D2 AZD2014 combination with AZD8186

Part A: AZD8186 monotherapy

Part B: AZD8186 monotherapy

Part C1: Abiraterone acetate combination with AZD8186

Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)

7 unique interventions2 categories

Analytics

Trial Phases

Phase 11

Trial Status

Completed4

Recruiting2

Role Distribution

Principal Investigator6

PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT05196087Recruiting

Breast CancerGastrointestinal Neuroendocrine TumorMelanoma

PrincipalinvestigatorStart date: 2022-07-20

NCT01884285Phase 1Completed

AZD8186 First Time In Patient Ascending Dose Study

Advanced Castrate-resistant Prostate Cancer CRPCSquamous Non-Small Cell Lung Cancer sqNSCLCTriple Negative Breast Cancer TNBC

PrincipalinvestigatorStart date: 2013-07-09

NCT01345513Completed

Feasibility Clinical Study of Targeted and Genome-Wide Sequencing

Solid Tumors

PrincipalinvestigatorStart date: 2011-03-01

NCT01543841Completed

Laboratory Testing for Tie-2 Expressing Monocytes (TEMs) in Blood

Advanced CancerHealthy

Principalinvestigator

NCT02724488Completed

Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies

Head and Neck CancerMelanoma

Principalinvestigator

NCT02906943Recruiting

Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

Breast CancerColorectal CancerGastrointestinal Cancer+8 more

Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Melanoma3 Breast Cancer2 Cancer of Head and Neck2 Advanced Cancer1 Advanced Castrate-resistant Prostate Cancer CRPC1 Colorectal Cancer1 Cancer of Gastrointestinal Tract1 Gastrointestinal Neuroendocrine Tumor1

Affiliations

Princess Margaret Hospital, Canada

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Philippe Bedard, MD

Princess Margaret Hospital, Canada

Very Similar

3 trials

Shared therapeutic areas:

Breast CancerColorectal CancerGenitourinary Cancer+9 more

Worked with same sponsors:

Princess Margaret Hospital, CanadaUniversity Health Network, Toronto

Collaborated on 2 trials

Similarity Score128%

Michele Mochetta, MD

AstraZeneca

Moderately Similar

1 trials

Shared therapeutic areas:

Advanced Castrate-resistant Prostate Cancer CRPCSquamous Non-Small Cell Lung Cancer SqNSCLCTriple Negative Breast Neoplasms

Worked with same sponsors:

AstraZeneca

Collaborated on 1 trial

Similarity Score34%

Lin Shen, MD

Peking University Cancer Hospital & Institute

20 trials

Shared therapeutic areas:

Colorectal CancerAdvanced CancerBreast Cancer+2 more

Similarity Score8%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

21 trials

Shared therapeutic areas:

Lung CancerBreast CancerColorectal Cancer+1 more

Similarity Score7%

Aminah Jatoi, MD

Mayo Clinic

29 trials

Shared therapeutic areas:

Lung CancerBreast CancerCancer of Head and Neck

Breast CancerColorectal CancerCancer of Head and Neck

Mark Levine, MD

Ontario Clinical Oncology Group (OCOG)

13 trials

Shared therapeutic areas:

Colorectal CancerMelanomaSolid Tumors

lin shen

Peking University Cancer Hospital & Institute

31 trials

Shared therapeutic areas:

Worked with same sponsors:

AstraZeneca

Breast CancerColorectal CancerTriple Negative Breast Neoplasms

Norman Wolmark, MD

NSABP Foundation Inc

54 trials

Shared therapeutic areas:

Worked with same sponsors:

AstraZeneca